Penetrating head trauma: Vancomycin 15 mg/kg q8h; + cefepime 50 mg/kg q8h or ceftazidime 50 mg/kg q8h or meropenem 40 mg/kg; + gentamicin 2.5 mg/kg q8h or amikacin 5–10 mg/kg q8h
Adults:
Ceftriaxone 2 g q12h or cefotaxime 2 g q4–6h; + vancomycin 15–20 mg/kg q8–12h (not to exceed 2 g/dose or 60 g/kg/d); + dexamethasone (15 mg/kg) up to 10 g q6h IV, continue for 4 days if causative agent is S. pneumoniae
>50 yr: Add ampicillin 2 g q4h to above regimen for Listeria coverage
Immune impaired: Vancomycin 15–20 mg/kg q8–12h + ampicillin 2 g q4h; + meropenem 2 g q8h or cefepime 2 g q8h
CNS surgery, shunt, head trauma: Vancomycin 15–20 mg/kg q8–12h; + meropenem 2 g
Vancomycin dosing for patients with normal renal function: 50–89 kg (1 g q12h), 90–130 kg (1.5 g q12h), >130 kg (2 g q12h)
Other medication considerations:
Dexamethasone:
Benefits are not conclusive.
May be beneficial for children with H. influenzae meningitis and may be beneficial in children >6 wk and adults with S. pneumoniae meningitis . May reduce neurologic sequelae
Give before or with antibiotics in patient with altered mental status, focal neurologic deficit, papilledema, or CNS trauma, surgery, or space-occupying lesion. Give if CSF is cloudy, has positive Gram stain, or >1,000 WBC/mm 3 .
Penicillin allergy (severe):
Aztreonam or chloramphenicol may be used in place of cephalosporins.
Do not delay therapy for lesser allergy history.
Vancomycin:
Add when concerned about penicillin-resistant pneumococcal infection.
Acyclovir if suspect herpes simplex virus encephalitis
MEDICATION
Acyclovir: 30 mg/kg/d q8h IV (Neonate: 20 mg/kg/d q8h IV)
Amikacin: Peds: 7.5 mg/kg q12h or 5 mg/kg q8h IV. Newborn: Load 10 mg/kg followed by 7.5 mg/kg q12h IV
Ampicillin: 2 g q4h (peds: 50–100 mg/kg q6h–q8h) IV, max. 12 g/d
Aztreonam: 2 g (peds: 30 mg/kg) q6–8h, max. 6–8 g/d IV
Bactrim: 5–10 mg/kg trimethoprim q12h IV
Cefepime: 2 g q8h, max. 6 g/d IV
Cefotaxime: 2 g (peds: 50 mg/kg) q6h, max. 8–12 g/d IV
Ceftazidime: 2 g q8h, max. 6 g/d IV
Ceftriaxone: 2 g (peds: 50–75 mg/kg) q12h, max. 4 g/d IV
Chloramphenicol: 1–1.5 g (peds: 12.5 mg/kg) q6h, max. 4–6 g/d IV
Dexamethasone: 10 mg (peds: 0.15 mg/kg) q6h IV for 4 days
Gentamicin: Peds: 2.5 mg/kg q8h IV
Meropenem: 2 g (peds 40 mg/kg) q8h IV, max. 6 g/d
Tobramycin: Peds: 2.5 mg/kg q8h IV
Vancomycin: 1–2 g q8–12h IV (peds: 15 mg/kg q8h)
Vancomycin and aminoglycosides: Adjust for renal function and serum concentration levels.
FOLLOW-UP DISPOSITION Admission Criteria
Known or suspected bacterial infection
Immune-compromised host
Any toxic-appearing patient
Discharge Criteria
Clear viral infection. Controlled symptoms.
Thorough and specific discharge instructions
Careful follow-up plan discussed with primary care physician prior to discharge
PEARLS AND PITFALLS
Meningitis generally does not present as uncomplicated febrile seizure in children.
Failure to diagnose or delay in treatment of meningitis results in catastrophic outcome for patients, and not infrequently, negative medicolegal consequences for the physicians involved.
ADDITIONAL READING
American Academy of Pediatrics. Red Book: 2012 Report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2012.
Chávez-Bueno S, McCracken GH Jr. Bacterial meningitis in children. Pediatr Clin North Am . 2005;52(3):795–810.
Fitch MT, van de Beek D. Emergency diagnosis and treatment of adult meningitis. Lancet Infect Dis . 2007;7(3):191–200.
Nelson JD, McCracken GH. Treatment of neonatal meningitis. Pediatr Infect Dis J . 2005;24(7).
Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for management of bacterial meningitis. Clin Infect Dis . 2004;39:1267–1284.
Upadhye S. Corticosteroids for acute bacterial meningitis. Ann Emerg Med . 2008;52:291–293.
van de Beek D, de Gans J, Tunkel AR, et al. Community-acquired bacterial meningitis in adults. N Engl J Med . 2006;354(1):44–53.